Clinical trials
Phase 2/3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 3 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Fujian Medical University | 1 |
| Gilead Sciences | 1 |
| Grupo Argentino de Tratamiento de la Leucemia Aguda | 1 |
| Ramón Óscar González-Ramella, Ph.D | 1 |
| Tehran University of Medical Sciences | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| Wei Zhao | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Leukemia | 4 |
| Leukemia, T-Cell | 2 |
| Burkitt Lymphoma | 1 |
| Leukemia, B-Cell | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma | 1 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.